Skip to content

EVALUATION OF THE RELATIONSHIP BETWEEN INFLAMMATION-PHYSICAL ACTIVITY AND THE ACTIVITY OF THE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS - ND

EVALUATION OF THE RELATIONSHIP BETWEEN INFLAMMATION-PHYSICAL ACTIVITY AND THE ACTIVITY OF THE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS - ND

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2007-002600-18-IT
Enrollment
50
Registered
2007-06-18
Start date
2007-06-05
Completion date
Unknown
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal obesity with metabolic syndrome MedDRA version: 6.1 Level: PT Classification code 10052066

Interventions

Trade Name: CARDIOASPIRIN*30CPR GAST 100MG Pharmaceutical Form: Gastro-resistant tablet INN or Proposed INN: Acetylsalicylic acid Concentration unit: mg milligram(s) Concentration type: equal Concentr

Sponsors

AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: One-hundred obese women (30Body Mass Index34.9 Kg/ m2) with abdominal body fat distribution (Waist to Hip ratio-WHR >0.85 e waist circumference > 88 cm) will be enrolled in the study. All women must have regular menses and must be aged between 25 and 45 years, in order to avoid bias on physical activity. Obese women must have one or more alterations of metabolic syndrome. Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Basing on physical examination, individual clinical history and lab tests, women suffered of diabetes, thyroid diseases, Cushing's syndrome, hyperandrogenism or systemic diseases will be excluded. Tendency to bleeding, estrogen treatment or pregnancy will be considered exclusion criteria.

Design outcomes

Primary

MeasureTime frame
Main Objective: This is a study of physiopatology that has to investigate the effect of physical activity, associated to low calorie diet regimen, on both the activity of the hypothalamic-pituitary-adrenal axis and inflammation and peripheral insulin sensibility.;Secondary Objective: The study will evaluate the eventual additive effect of aspirin treatment on the same parameters. These data will give informations about the relationship between the acute-phase proteins, cytokines, glucocorticoids and physical activity;Primary end point(s): Evaluation of physical activity effect alone or in combination with pharmacological treatment (aspirin) on flogosis and, then, on the activity of the HPA axis (urinary free cortisol excretion)

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026